Therapy of lung diseases
Together with partners in Munich and around the world, ISAR Bioscience is developing novel therapies for the treatment of acute and chronic lung diseases.
Lipid nanoparticles (LNPs) for RNA medicine and Tolero-LNPs
Lipid nanoparticles protect novel RNA-based drugs and deliver them to their sites of action in the body. ISAR Bioscience aims to reduce side effects and to make them more powerful.
New immunotherapies from induced stem cells
ISAR Bioscience aims to teach iPS cells how to fight autoimmune diseases in an effective and sustained manner.
Antibodies against Alzheimer’s dementia
ISAR Bioscience develops novel antibodies directed against a protein relevant for Alzheimer’s disease. First results are encouraging.
